Veeva Systems Inc Class A (VEEV)vsScworx Corp (WORX)
VEEV
Veeva Systems Inc Class A
$178.11
-0.56%
HEALTHCARE · Cap: $29.44B
WORX
Scworx Corp
$0.13
+1.50%
HEALTHCARE · Cap: $2.01M
Smart Verdict
WallStSmart Research — data-driven comparison
Veeva Systems Inc Class A generates 114653% more annual revenue ($3.20B vs $2.78M). VEEV leads profitability with a 28.4% profit margin vs -139.7%. VEEV earns a higher WallStSmart Score of 69/100 (B-).
VEEV
Strong Buy69
out of 100
Grade: B-
WORX
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+25.9%
Fair Value
$238.92
Current Price
$178.11
$60.81 discount
Intrinsic value data unavailable for WORX.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Keeps 28 of every $100 in revenue as profit
Growing faster than its price suggests
Strong operational efficiency at 29.4%
16.0% revenue growth
Earnings expanding 23.2% YoY
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -74.2% — below average capital efficiency
Revenue declined 7.1%
Comparative Analysis Report
WallStSmart ResearchBull Case : VEEV
The strongest argument for VEEV centers on Debt/Equity, Profit Margin, PEG Ratio. Profitability is solid with margins at 28.4% and operating margin at 29.4%. Revenue growth of 16.0% demonstrates continued momentum.
Bull Case : WORX
The strongest argument for WORX centers on Price/Book, Debt/Equity.
Bear Case : VEEV
The primary concerns for VEEV are P/E Ratio.
Bear Case : WORX
The primary concerns for WORX are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
VEEV profiles as a growth stock while WORX is a turnaround play — different risk/reward profiles.
WORX carries more volatility with a beta of 2.02 — expect wider price swings.
VEEV is growing revenue faster at 16.0% — sustainability is the question.
VEEV generates stronger free cash flow (100M), providing more financial flexibility.
Bottom Line
VEEV scores higher overall (69/100 vs 31/100), backed by strong 28.4% margins and 16.0% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Veeva Systems Inc Class A
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.
Visit Website →Scworx Corp
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Scworx Corp (WORX) is a leading provider of advanced healthcare data solutions, focused on streamlining clinical data and insights for healthcare providers and stakeholders. Leveraging innovative technology, Scworx enhances operational efficiency and elevates care quality, enabling institutions to make data-driven decisions through comprehensive analytics. The company's strategic emphasis on scalability and innovation positions it well to address the increasing demand for data-centric solutions in the healthcare sector, ultimately driving improved patient outcomes and fostering effective cost management strategies. Scworx's commitment to transforming healthcare delivery underscores its pivotal role in a rapidly evolving market landscape.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?